company background image
OPNT logo

Opiant Pharmaceuticals NasdaqCM:OPNT Voorraadrapport

Laatste prijs

US$20.65

Marktkapitalisatie

US$108.8m

7D

-1.3%

1Y

-22.3%

Bijgewerkt

03 Mar, 2023

Gegevens

Financiële gegevens bedrijf +

Opiant Pharmaceuticals, Inc.

NasdaqCM:OPNT Voorraadrapport

Marktkapitalisatie: US$108.8m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

OPNT Overzicht aandelen

Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose.

Opiant Pharmaceuticals, Inc. Concurrenten

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Opiant Pharmaceuticals
Historische aandelenkoersen
Huidige aandelenkoersUS$20.65
52 Week HoogtepuntUS$28.15
52 Week LaagUS$7.34
Bèta0.83
11 maand verandering3.10%
3 maanden verandering2.38%
1 Jaar Verandering-22.31%
33 jaar verandering70.80%
5 jaar verandering1.77%
Verandering sinds IPO-82.79%

Recent nieuws en updates

Recent updates

Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Analysts Just Slashed This Year's Estimates

Aug 13
Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Analysts Just Slashed This Year's Estimates

Opiant awarded additional $2.1M from BARDA for its nasal opioid overdose treatment

Aug 08

Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Shares Could Be 47% Below Their Intrinsic Value Estimate

Aug 05
Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Shares Could Be 47% Below Their Intrinsic Value Estimate

Analysts Just Made A Major Revision To Their Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Revenue Forecasts

Mar 21
Analysts Just Made A Major Revision To Their Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Revenue Forecasts

Opiant Pharmaceuticals (NASDAQ:OPNT) Is Posting Healthy Earnings, But It Is Not All Good News

Nov 19
Opiant Pharmaceuticals (NASDAQ:OPNT) Is Posting Healthy Earnings, But It Is Not All Good News

These 4 Measures Indicate That Opiant Pharmaceuticals (NASDAQ:OPNT) Is Using Debt Reasonably Well

Nov 17
These 4 Measures Indicate That Opiant Pharmaceuticals (NASDAQ:OPNT) Is Using Debt Reasonably Well

Opiant Pharmaceuticals: Assessing Recent Insider Buying

Sep 19

Party Time: Brokers Just Made Major Increases To Their Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Earnings Forecasts

Aug 07
Party Time: Brokers Just Made Major Increases To Their Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Earnings Forecasts

Increases to CEO Compensation Might Be Put On Hold For Now at Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT)

Jun 09
Increases to CEO Compensation Might Be Put On Hold For Now at Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT)

The Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Yearly Results Are Out And Analysts Have Published New Forecasts

Mar 06
The Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Yearly Results Are Out And Analysts Have Published New Forecasts

News Flash: Analysts Just Made A Substantial Upgrade To Their Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Forecasts

Mar 05
News Flash: Analysts Just Made A Substantial Upgrade To Their Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Forecasts

Opiant Pharmaceuticals'(NASDAQ:OPNT) Share Price Is Down 41% Over The Past Three Years.

Jan 27
Opiant Pharmaceuticals'(NASDAQ:OPNT) Share Price Is Down 41% Over The Past Three Years.

Opiant Pharma secures additional BARDA grant of $3.5M for OPNT003

Dec 14

Opiant Pharmaceuticals receives $50M in convertible debt financing

Dec 10

Rendement voor aandeelhouders

OPNTUS PharmaceuticalsUS Markt
7D-1.3%-3.7%0.5%
1Y-22.3%22.6%36.8%

Rendement versus industrie: OPNT presteerde slechter dan de US Pharmaceuticals -sector, die het afgelopen jaar een rendement van 22.6 % opleverde.

Rendement versus markt: OPNT presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 36.8 % opleverde.

Prijsvolatiliteit

Is OPNT's price volatile compared to industry and market?
OPNT volatility
OPNT Average Weekly Movement1.5%
Pharmaceuticals Industry Average Movement9.4%
Market Average Movement6.1%
10% most volatile stocks in US Market15.0%
10% least volatile stocks in US Market3.0%

Stabiele aandelenkoers: OPNT heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit van OPNT is het afgelopen jaar gedaald van 19% naar 1%.

Over het bedrijf

OpgerichtWerknemersCEOWebsite
200538Roger Crystalwww.opiant.com

Opiant Pharmaceuticals, Inc. Samenvatting

Hoe verhouden de winst en inkomsten van Opiant Pharmaceuticals zich tot de beurswaarde?
OPNT fundamentele statistieken
MarktkapitalisatieUS$108.80m
Inkomsten(TTM)-US$33.09m
Inkomsten(TTM)US$22.34m

4.9x

P/S-verhouding

-3.3x

Koers/Winstverhouding

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
OPNT resultatenrekening (TTM)
InkomstenUS$22.34m
Kosten van inkomstenUS$29.45m
Brutowinst-US$7.11m
Overige uitgavenUS$25.97m
Inkomsten-US$33.09m

Laatst gerapporteerde inkomsten

Sep 30, 2022

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)-6.28
Brutomarge-31.85%
Nettowinstmarge-148.12%
Schuld/Eigen Vermogen Verhouding67.1%

Hoe presteerde OPNT op de lange termijn?

Bekijk historische prestaties en vergelijking